Tilray Brands (TLRY) Total Non-Current Liabilities (2019 - 2026)

Tilray Brands (TLRY) posted Total Non-Current Liabilities of $549.0 million for Q1 2026, little changed on a QoQ basis from $551.7 million in Q4 2025.

Tilray Brands (TLRY) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Tilray Brands' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $549.0 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities changed N/A year-over-year to $549.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $549.0 million (changed N/A YoY) and the FY2025 annual result came in at $583.9 million, down 24.99% from the prior year.
  • Total Non-Current Liabilities was $549.0 million for Q1 2026 at Tilray Brands, roughly flat from $551.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.2 billion in Q1 2022 and bottomed at $549.0 million in Q1 2026.
  • A 5-year average of $841.6 million and a median of $903.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slumped 35.52% — and 2023, when it fell 3.08%.
  • Tilray Brands' Total Non-Current Liabilities stood at $991.0 million in 2022, then decreased by 5.43% to $937.2 million in 2023, then declined by 21.24% to $738.1 million in 2024, then retreated by 25.26% to $551.7 million in 2025, then decreased by 0.49% to $549.0 million in 2026.
  • Business Quant data shows TLRY's Total Non-Current Liabilities at $549.0 million in Q1 2026, $551.7 million in Q4 2025, and $562.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn 548.95 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 548.95 Mn
Nov 30, 2025 551.67 Mn
Aug 31, 2025 561.99 Mn
May 31, 2025 583.90 Mn
Nov 30, 2024 738.13 Mn
Aug 31, 2024 778.35 Mn
May 31, 2024 778.40 Mn
Feb 29, 2024 869.61 Mn
Nov 30, 2023 937.20 Mn
Aug 31, 2023 987.69 Mn
May 31, 2023 977.10 Mn
Feb 28, 2023 965.79 Mn
Nov 30, 2022 991.05 Mn
Aug 31, 2022 1.03 Bn
May 31, 2022 1.01 Bn
Feb 28, 2022 1.16 Bn
Nov 30, 2021 1.29 Bn
Aug 31, 2021 1.60 Bn
May 31, 2021 1.56 Bn
Mar 31, 2020 719.84 Mn